Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net Income (Loss)	$ (946,872)	$ (1,064,090)
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	29,810	29,842
Stock based compensation or services	288,942	415,297
Loss on Disposal of assets		369
Changes in operating assets and liabilities
Prepaid expenses	2,999	(18,000)
Accrued interest - related party	42,092	6,712
Accounts payable and accrued liabilities	328,184	19,559
Right of use lease	(1,019)	1,192
Net cash used in operating activities	(255,864)	(609,119)
Cash flows from investing activities
Net Purchase of property and equipment		(282,038)
Patent Costs	(20,825)	(12,621)
Net cash used in investing activities	(20,825)	(294,659)
Cash flows from financing activities
Proceeds from exercise of warrants and options		72,250
Chapter 11 Settlement		(50,000)
Net Proceeds from the issuance of Convertible Notes	260,000	250,000
Net proceeds from issuance of common stock		582,750
Net cash provided by financing activities	260,000	855,000
Net decrease in cash and cash equivalents	(16,689)	(48,778)
Cash and cash equivalent at beginning of the period	41,008	211,901
Cash and cash equivalent at end of the period	$ 24,319	$ 163,123